First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Hits New 52-Week High – What’s Next?

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) hit a new 52-week high on Wednesday . The company traded as high as $229.01 and last traded at $229.0890, with a volume of 3758 shares changing hands. The stock had previously closed at $226.09.

First Trust NYSE Arca Biotechnology Index Fund Trading Up 1.9%

The company has a market cap of $2.57 billion, a P/E ratio of 21.72 and a beta of 0.68. The company has a 50 day moving average price of $210.73 and a 200-day moving average price of $209.13.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Several institutional investors and hedge funds have recently modified their holdings of the business. Dynamic Wealth Strategies LLC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 10.8% during the 4th quarter. Dynamic Wealth Strategies LLC now owns 515 shares of the company’s stock worth $106,000 after buying an additional 50 shares during the last quarter. Sequent Planning LLC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 4.5% during the 1st quarter. Sequent Planning LLC now owns 1,150 shares of the company’s stock worth $231,000 after buying an additional 50 shares during the last quarter. Kestra Private Wealth Services LLC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 0.6% during the 4th quarter. Kestra Private Wealth Services LLC now owns 8,919 shares of the company’s stock worth $1,842,000 after buying an additional 53 shares during the last quarter. Signaturefd LLC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 30.6% during the 4th quarter. Signaturefd LLC now owns 235 shares of the company’s stock worth $49,000 after buying an additional 55 shares during the last quarter. Finally, Bedell Frazier Investment Counselling LLC lifted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 1.8% during the 3rd quarter. Bedell Frazier Investment Counselling LLC now owns 3,200 shares of the company’s stock worth $574,000 after buying an additional 57 shares during the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.